ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Long Shan Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112902878. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2011: 1 paper

Papers 1

Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy. Co-author DOI 10.1158/1078-0432.ccr-10-1983 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Carlton C. Barnett · 1 shared paper, 2011 · strength 0.02
- Paper Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer t… DOI 10.1158/1078-0432.ccr-10-1983 ↗
David A. Boothman · 1 shared paper, 2011 · strength 0.02
- Paper Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer t… DOI 10.1158/1078-0432.ccr-10-1983 ↗
Rolf A. Brekken · 1 shared paper, 2011 · strength 0.02
- Paper Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer t… DOI 10.1158/1078-0432.ccr-10-1983 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.